Combination Effect of Calcium Channel Blocker and Valsartan on Cardiovascular Event Prevention in Patients with High-Risk Hypertension: Ancillary Results of the KYOTO HEART Study

Author： Sawada Takahisa   Yamada Hiroyuki   Shiraishi Jun   Kimura Shinzo   Matsubara Hiroaki  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.34, Iss.2, 2012-04, pp. : 153-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Effect of Combination Therapy with an Angiotensin II Receptor Blocker and Either a Low-Dose Diuretic or Calcium Channel Blocker on Cardiac Hypertrophy in Patients with Hypertension

By Okura Takafumi   Miyoshi Ken-ichi   Irita Jun   Enomoto Daijiro   Jotoku Masanori   Nagao Tomoaki   Watanabe Kouki   Matsuoka Hiroshi   Ashihara Toshiaki   Higaki Jitsuo  

Clinical and Experimental Hypertension, Vol. 35, Iss. 8, 2013-12 ,pp. : 563-569

Informa Healthcare

Access to resources Recommend Favorite

Renoprotective Effect of Calcium Channel Blockers in Combination with an Angiotensin Receptor Blocker in Elderly Patients with Hypertension. A Randomized Crossover Trial Between Benidipine and Amlodipine

By Miyagawa Koichi   Dohi Yasuaki   Nakazawa Ai   Sugiura Tomonori   Yamashita Sumiyo   Sato Koichi   Kimura Genjiro  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Effects of Exercise Therapy Alone and in Combination with a Calcium Channel Blocker or an Angiotensin Receptor Blocker in Hypertensive Patients

By Ohta Masanori   Tajiri Yuji   Yamato Hiroshi   Ikeda Masaharu  

Clinical and Experimental Hypertension, Vol. 34, Iss. 7, 2012-11 ,pp. : 523-529

Informa Healthcare

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy Comprising Angiotensin II Receptor Blocker Plus Calcium Channel Blocker on Plasma Adiponectin Levels

By Inoue Yukiko   Kakuma Tatsuyuki   Nonaka Yoshisuke   Sumi Shunichiro   Okamura Keisuke   Kodama Sunao   Ando Chie   Niimura Hideya   Miyoshi Kei   Tsuchiya Yoshihiro   Yamanouchi Yoshio   Urata Hidenori  

Clinical and Experimental Hypertension, Vol. 32, Iss. 1, 2010-02 ,pp. : 21-28

Informa Healthcare

Access to resources Recommend Favorite

Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk

By Weber Michael A.   Bakris George L.   Dahlöf Björn   Pitt Bertram   Velazquez Eric   Gupte Jitendra   Lefkowitz Martin   Hester Allen   Shi Victor   Weir Matthew   Kjeldsen Sverre   Massie Barry   Nesbitt Shawna   Ofili Elizabeth   Jamerson Kenneth   Investigators for the Accomplish  

Blood Pressure, Vol. 16, Iss. 1, 2007-01 ,pp. : 13-19

Informa Healthcare

Access to resources Recommend Favorite